Clinical Trials Browser

Phase NA × INDUSTRY × Recurrence × Clear all

Brain Neoplasms, Neoplasm Metastasis, Recurrence

NCT04540588 2025-12-02

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Lip Neoplasms, Recurrence, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Tongue Neoplasms

NCT05047094 2025-12-02

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

Phase NA Recruiting

48 enrolled

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT04933825 2023-02-17

A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)

Phase NA Unknown

18 enrolled

Recurrence

NCT00772317 2019-04-10

STAR

Phase NA Unknown

117 enrolled

Genitourinary

Prostatic Neoplasms, Recurrence

NCT02323854 2018-05-07

EMPRESS

Phase NA Completed

15 enrolled 10 charts

Thoracic

Lung Neoplasms, Recurrence

NCT02919046 2017-03-14

Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children

Phase NA Unknown

22 enrolled

CNS

Neuroblastoma, Recurrence

NCT02997241 2016-12-20

CCTDRP

Phase NA Unknown

500 enrolled

Gastrointestinal

Colonic Neoplasms, Recurrence

Clinical Trials

REMASTer: REcurrent Brain Metastases After SRS Trial

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC

A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)

STAR

EMPRESS

Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children

CCTDRP